TruSpine Technologies Plc

Transaction in Own Shares • Jul 1, 2025

National Storage Mechanism | Additional information

RNS Number : 0812P

TruSpine Technologies PLC

01 July 2025

1 July 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

Convertible Loan Note Extension & Related Party Transaction

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that further to the announcement on 24 July 2024, the Company has extended the maturity date of the convertible loan note ("CLN") to 30 June 2026. All other terms of the CLN remain unchanged.

Following the announcement of 23 May 2023, Axis MedTech (Holdings) Limited ("Axis") holds £136,573 of CLNs. Geoff Miller and Sam Ogunsalu, both directors of the Company, are directors and shareholders of Axis as at the date of this announcement.

Related Party Transaction

The extension of maturity date of the CLN (the "Transaction") is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook, by virtue of the Company and Geoff Miller, Non-executive Chairman of the Company, and Sam Ogunsalu, Non-executive Director of the Company, being each a party to the CLN. The director of TruSpine independent of the Transaction, Victoria Sena, confirms that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of TruSpine are concerned.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

-END-

TruSpine Investor Hub	https://investorhub.truspinetech.com
TruSpine Technologies Plc	Tel: +44 (0)20 7118 0852
Geoff Miller, Non-executive Chairman
Cairn Financial Advisers LLP (AQSE Corporate Adviser)	Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Peterhouse Capital Limited (Broker & Financial Adviser)	Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: +44 (0)1273 704 473
Alan Green / Jacqueline Briscoe	[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXBIGDLRBXDGUG